Article information
Full text is only aviable in PDF
Bibliografía
[1.]
A. López Encuentra, C. León González, J. López Mejías, (Grupo de Trabajo de la SEPAR), et al.
Normativa sobre nomenclatura y clasificación del carcinoma broncogénico.
Ed. Doyma S.A, (1986),
[2.]
A. López Encuentra.
La clasificación TNM del carcinoma broncogénico.
Seis años después. Arch Bronconeumol, 28 (1992), pp. 360-364
[3.]
T.W. Shields.
The significance of ipsilateral mediastinal lymph node metástasis (N2 disease) in non small cell carcinoma of the lung: A comentary.
J Thorac Cardiovasc Surg, 99 (1990), pp. 48-53
[4.]
R.G. Fosburg, M.J. O'Sullivan, P. Al-Tye, J.A. Gibbons, J.N. Oury.
Positive mediastinoscopy: an ominous finding.
Ann Thorac Surg, 18 (1974), pp. 346-356
[5.]
R.O. Dillman, S.L. Seagren, J. Propert, et al.
A randomized trial of induction chemotherapy plus high-dose radiation versus radiation alone in stage III non-small-cell lung cancer.
N Engl J Med, 323 (1990), pp. 940-945
[6.]
H. Kreisman, A. Lisbona, L. Olson, et al.
Effect of prestudy tumor stage and of chemotherapy-radiotherapy (CT-RT) in non-small cell lung cancer (NSCLC).
Chest, 98 (1990), pp. 107s
[7.]
G.M. Strauss, J.E. Herndon, D.D. Sherman, et al.
Neoadjuvant chemotherapy and radiotherapy followed by surgery in stage IIIA non-small-cell carcinoma of the lung: report of a Cancer and Leukemia Group B phase II study.
J Clin Oncol, 10 (1992), pp. 1.237-1.244
[8.]
R.J. Ginsberg.
Multimodality therapy for stage IIIA (N2) lung cancer.
An overview. Chest, 103 (1993), pp. 356-359
[10.]
Y. Watanabe, Y. Hayashi, M. Oda, T. Iwa.
Mediastinal nodal involvement and the prognosis of non-small cell lung cancer.
Chest, 100 (1991), pp. 422-428
[11.]
M. Larrson.
Pretreatment classification and staging of bronchogenic carcinoma.
Scand J Thorac Cardiovasc Surg, 10 (1973), pp. 304-308
[12.]
F.G. Pearson, N.C. Delaure, R. Ilves, T.R.J. Todd, J.D. Cooper.
Significance of positive superior mediastinal nodes identified at mediastinoscopy in patients with resectable cancer of the lung.
J Thorac Cardiovasc Surg, 83 (1982), pp. 1-11
[13.]
J. Padilla Alarcón.
Factores pronósticos en el tratamiento quirúrgico del carcinoma broncopulmonar con afectación de ganglios mediastínicos.
Análisis multivariado de 68 pacientes. Cir Esp, 46 (1989), pp. 122-127
[14.]
N. Martini, B.J. Flehinger.
The role of surgery in N2 lung cancer.
Surg Clin North Am, 67 (1987), pp. 1.037-1.049
[15.]
T. Naruke, T. Goya, R. Tsuchiya, K. Suemasn, et al.
The importance of surgery to non-small cell carcinoma of the lung with mediastinal lymph node metastases.
Ann Thorac Surg, 46 (1988), pp. 603-610
[16.]
W.P. Luke, F.G. Pearson, T.R.J. Todd, G.A. Patterson, J.D. Cooper.
Prospective evaluation of mediastinoscopy for assessment of carcinoma of the lung.
J Thorac Cardiovasc Surg, 91 (1986), pp. 53-56
[17.]
G.A. Patterson, R.J. Ginsberg, P.Y. Poon, et al.
A prospective evaluation of magnetic resonance imaging, computed tomography, and mediastinoscopy in the preoperative assessment of mediastinal node status in bronchogenic carcinoma.
J Thorac Cardiovasc Surg, 94 (1987), pp. 679-684
[18.]
T.C. McLoud, P.M. Bourgouin, R.W. Greenberg, et al.
Bronchogenic carcinoma: Analysis of staging in the mediastinum with CT by correlative node mapping and sampling.
Radiology, 182 (1992), pp. 319-323
[19.]
P.C. Jolly, C.H. Hutchinson, F. Detterbeck, S.W. Guyton, B. Hofer, R.P. Anderson.
Routine computed tomographic scans, selective mediastinoscopy, and other factors in evaluation of lung cancer.
J Thorac Cardiovasc Surg, 102 (1991), pp. 266-271
[20.]
B.D.T. Daly, J.D. Mueller, L.J. Falling, et al.
N2 lung cancer: Outcome in patients with false-negative computed tomographic scans of the chest.
J Thorac Cardiovasc Surg, 105 (1993), pp. 904-911
[21.]
J.M. Aronchick.
CT of mediastinal lymph nodes in patients with non-small cell lung carcinoma.
Radiol Clin North Am, 28 (1990), pp. 573-581
[22.]
I.J. Cybulsky, L.A. Lanza, B. Ryan, J.B. Putman, M.M. McMurtrey, I.A. Roth.
Prognostic significance of computed tomography in resected N2 lung cancer.
Ann Thorac Surg, 54 (1992), pp. 533-537
[23.]
D.J. Sugarbaker, G.M. Strauss.
Advances in surgical staging and therapy of non-small-cell lung cancer.
Semin Oncol, 20 (1993), pp. 163-172
[24.]
K.S. Albain.
Induction therapy followed by definitive local control for stage III non-small-cell lung cancer. A review, with a focus on recent trimodality trials.
Chest, 103 (1993), pp. 43-50
[25.]
E.C. Holmes.
Preoperative neoadjuvant therapy in non-small-cell lung cancer: Open season?.
J Natl Cancer Inst, 83 (1991), pp. 228-229
[26.]
G.M. Strauss, M.P. Langer, A.D. Elias, A.T. Skarin, D.J. Sugarbaker.
Multimodality treatment of stage IIIA non-small-cell lung carcinoma: A critical review of the literature and strategies for the future research.
J Clin Oncol, 10 (1992), pp. 829-838
[27.]
P.A. Thomas, S. Piantadosi, C.F. Mountain.
The Lung Cancer Study Group: Should subcarinal lymph nodes be routinely examined in patients with non-small-cell lung cancer?.
J Thorac Cardiovasc Surg, 95 (1988), pp. 883-887
Copyright © 1994. Sociedad Española de Neumología y Cirugía Torácica
